Akamai Technologies (AKAM) shares were down over 17% in recent Friday trading after several analysts downgraded the stock following its Q4 results and guidance.
BofA downgraded the stock to neutral from buy and cut its price target to $100 from $125, saying that its "muted" outlook suggests that this year will likely be one of transition.
Other analysts also downgraded the stock, including from Craig-Hallum, Piper Sandler, and TD Cowen.
Separately, Morgan Stanley cut its price target to $102 from $108 while keeping an equalweight rating.
"FY25 guidance came in below estimates on all fronts, with EPS guided to decline YoY," Morgan Stanley said. "We remain EW awaiting signs that top-line can see more durable acceleration."
JPMorgan also cut its price target to $72 from $76, and RBC to $90 from $100.
Trading volume stood at over 11 million shares against a daily average of almost 1.7 million.
Price: 81.11, Change: -16.93, Percent Change: -17.27
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.